Gestational Diabetes Clinical Trial
Official title:
The Effect of Steroids for Fetal Lung Maturity on Maternal Glucose Levels
This study will look at blood sugar levels in pregnant women who have been given a glucocorticoid (steroid) medication to enhance fetal lung maturity. The findings will help determine the likelihood, predictive value, adverse effects, response of patients diagnosed with gestational diabetes and time course of blood sugar elevation following steroids.
Few studies have examined the effects on maternal glucose levels from corticosteroids, which
are given during some complicated pregnancies to enhance fetal lung maturity when early
delivery is expected. The applicability of these studies is limited by the presence of
confounding factors and low numbers of participants (ranging between 7 and 50). Two relevant
studies are by Mastrobiattista at al and Gurbuz et al. These studies had 7 and 40 subjects
respectively, and studied the change in maternal 1-hour glucose tolerance tests following
administration of steroids for fetal lung maturity. The 1-hour tests involve a standard oral
glucose challenge and are used to screen for gestational diabetes; thus, they may not reflect
the changes in circulating glucose levels from typical sources of glucose (such as meals)
anticipated with steroid administration. Both studies showed a change in the results of
glucose tolerance testing and concluded that screening for gestational diabetes should be
delayed at least 72 hours to 1 week after completion of the steroid course. Neither study
looked at maternal glucose values within the first 48 hours of giving the first dose of
steroids, and neither addressed whether diabetes could be diagnosed alternatively by the
maternal glucose response within the first 48 hours following steroid administration.
It has been the investigator's clinical observation that glucose values may be highest during
those first 48 hours. Another study looked at the effect of various doses of insulin on the
degree of hyperglycemia for the first 3 days following steroid administration and showed
increases in glucose values even in the insulin-treated. Unfortunately, some subjects in that
study had concurrent treatment with another agent known to cause hyperglycemia.
No standards of care exist to guide whether to monitor glucose values after steroid
administration for fetal lung maturity. The time course of glucose elevations is not clear,
and how often the glucose elevations reach a level that would generally warrant treatment is
unknown. When glucose monitoring is performed, no standard exists to guide the duration or
frequency of monitoring.
Detecting maternal hyperglycemia is important for several reasons, including:
1. High maternal glucose levels lead to high fetal levels and prompt a fetal response to
the high glucose levels. Some of the pregnancies may go on to deliver while the maternal
glucose levels are still high, resulting in a higher risk of neonatal hypoglycemia in
the nursery and an increased risk of acidosis and injury in the brain if periods of
distress occur during labor. By the nature of the clinical situations, most fetuses born
in the first few days following administration of steroids will also be preterm and
possibly already have additional factors which put them at risk for complications in
labor and the nursery, so the hyperglycemia compounds the risk for them.
2. The maternal hyperglycemia may complicate the maternal course at a time when the
pregnant woman is receiving other medications to control her premature labor or
obstetric condition that prompted the use of the steroids in the first place. Fluid
balance and constitutional symptoms may be affected by high glucose values. Rarely,
diabetic ketoacidosis may be precipitated in someone with no history of diabetes.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05081037 -
Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS)
|
N/A | |
Active, not recruiting |
NCT03249896 -
Web/Smartphone-based Lifestyle Coaching Program in Pregnant Women With Gestational Diabetes
|
N/A | |
Terminated |
NCT03749889 -
Low Carb vs Normal Carb in Pregnancy
|
N/A | |
Completed |
NCT03859193 -
Education Nutritional Video for Gestational Diabetics
|
N/A | |
Recruiting |
NCT05037526 -
Utility of Real Time Continuous Glucose Monitoring in the Care of Gestational Diabetes Versus Standard Care in Pregnancy Outcomes
|
N/A | |
Completed |
NCT06178250 -
Placenta, Fetal Liver, Sectional Ductus Venosus Volumes Examined by Three-dimensional Ultrasound in the Second Trimester
|
N/A | |
Not yet recruiting |
NCT06310356 -
Continuous Glucose Monitoring for Women With Gestational Diabetes
|
N/A | |
Not yet recruiting |
NCT06445530 -
Nutrition Optimization and Community Upliftment for Postpartum Recovery
|
N/A | |
Recruiting |
NCT02590016 -
Glucose Control During Labour in Gestational Diabetes Mellitus With Insulin Treatment: A Randomized Controlled Trial
|
Phase 4 | |
Withdrawn |
NCT01947699 -
Glycemic Profile in Women With Gestational Diabetes Treated With Glyburide
|
Phase 4 | |
Not yet recruiting |
NCT00883259 -
Metformin and Gestational Diabetes in High-risk Patients: a RCTs
|
Phase 4 | |
Recruiting |
NCT03008824 -
Micronutrients in Pregnancy as a Risk Factor for Diabetes and Effects on Mother and Baby
|
N/A | |
Active, not recruiting |
NCT01340924 -
Relationship Between Gestational Diabetes and Type 2 Diabetes
|
||
Completed |
NCT00534105 -
Lipid Metabolism in Gestational Diabetes
|
N/A | |
Recruiting |
NCT00371306 -
Comparison of Glucovance to Insulin for Diabetes During Pregnancy
|
N/A | |
Completed |
NCT03388723 -
Intergenerational Programming of Diabesity in Offspring of Women With Gestational Diabetes Mellitus
|
||
Recruiting |
NCT04521712 -
Postpartum Glycemia in Women at Risk For Persistent Hyperglycemia
|
N/A | |
Enrolling by invitation |
NCT03307486 -
Gestational Diabetes: a Cohort Study
|
N/A | |
Active, not recruiting |
NCT03301792 -
Group Versus Traditional Prenatal Care for Diabetes
|
N/A | |
Enrolling by invitation |
NCT05603793 -
YoUng Adolescents' behaViour, musculoskeletAl heAlth, Growth & Nutrition
|